An interventional study of narrow band imaging withdrawal and white light withdrawal in Colon Cancer and Colon Sessile Serrated Adenoma/Polyp, sponsored by Hospital Beatriz Ângelo. Status unknown at 3 sites in Portugal. Open to participants aged 40 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-26.
Sponsored by Hospital Beatriz Ângelo · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Colonic Neoplasms with a site in Portugal — 2 open to participants now, 3 under way, 2 of them phase 3. Colonic Neoplasms · Portugal.
Among the 18 studies in Colonic Neoplasms with a site in Portugal, this one is the 5th largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2016, is one of 4 with no phase, and was the 10th registered.
2,457 studies on the registry are indexed under Colonic Neoplasms; 456 are open to participants now.
Browse Colonic Neoplasms studies →2 of the 18 studies in Colonic Neoplasms with a site in Portugal are open now. Recruiting first, the newest first:
ADVANCED MARKER DISCOVERY S.L. · Sites in Portugal, Spain
Ages 50–69 · Healthy volunteers
GlaxoSmithKline · Sites in Portugal, United States, Argentina and 25 more countries
Ages 18+
A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →
Of the 326 Colonic Neoplasms studies recruiting now, 202 (62%) set no upper age limit and 72 (22%) stop at 75 or younger; 19 take children under 18; 35 take healthy volunteers.
This study: 40 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 1 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 987 is above the median of 75 across 1,711 interventional studies indexed under Colonic Neoplasms.
Median enrollment 874 across the 12 interventional studies, 613 across the 3 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 18 have an industry lead sponsor. The 10 most frequent:
Hospital Beatriz Ângelo is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Hospital Beatriz Ângelo has 1 study filed under Colonic Neoplasms — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Colonic Neoplasms with a site in Portugal, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Colorectal cancer (CRC) is a leading cause of cancer death and its' incidence is rising in most European countries. Colonoscopy has been shown to reduce CRC incidence, however its effectiveness depends on the sensitivity to detect pre-malignant lesions.
Our aim is to evaluate narrow band imaging (NBI) during colonoscopy and serum miRNAs as novel tools for the early detection of colonic sessile serrated lesions (SSL). The investigators will perform a multicenter-randomized-controlled-trial to study the role of NBI in SSL detection.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
colonoscope withdrawal and mucosal inspection performed under narrow band imaging
Device: narrow band imaging withdrawal
colonoscope withdrawal and mucosal inspection performed under white light imaging
Device: white light withdrawal
colonoscope withdrawal and mucosal inspection performed under narrow band imaging
colonoscope withdrawal and mucosal inspection performed under white light imaging
average number of serrated lesions ≥10 mm detected per colonoscopy
Time frame: immediate
Serrated class lesions detection rate
number of patients with at least 1 lesion/total number of participants
Time frame: immediate
Serrated lesions <10 mm detected per colonoscopy
Time frame: immediate
SSL detection rate
histologically defined according to the WHO criteria
Time frame: immediate
Adenoma detection rate
number of patients with at least 1 adenoma/total number of participants
Time frame: immediate
Adenomas detected per colonoscopy
Time frame: immediate
Advanced (malignant) adenocarcinoma detection rate
Time frame: immediate
Incidence of procedure related adverse events
Time frame: immediate
Plan to share: No
The record gives a start of Nov 2016, a primary completion of Aug 2019 and a completion of Aug 2019. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Beatriz Ângelo